Evanson Jeff 4
4 · Outlook Therapeutics, Inc. · Filed Apr 21, 2020
Insider Transaction Report
Form 4
Evanson Jeff
Chief Commercial Officer
Transactions
- Award
Common Stock
2020-03-19+1,207,457→ 1,207,457 total
Footnotes (1)
- [F1]These shares were issued to the Reporting Person pursuant to the terms of that certain Consulting Agreement dated January 27, 2020, and are subject to repurchase by the Issuer as provided therein.